Literature DB >> 30693274

Erratum: Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy?

.   

Abstract

[This corrects the article DOI: 10.3389/fcimb.2018.00419.].

Entities:  

Keywords:  Plasmodium; apoptosis; eryptosis; host-directed therapy; host-pathogen interaction; malaria; programmed cell death

Year:  2019        PMID: 30693274      PMCID: PMC6340367          DOI: 10.3389/fcimb.2018.00455

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


Due to a production error, two sub-section titles lacked the capitalization of “P” for Plasmodium in “Plasmodium-Infected Erythrocytes: a Fight Between Life and Death" and “Plasmodium Induces Eryptosis of Bystander Erythrocytes.” Secondly, in Table 4 (see below), “uRBC” and “iRBC” column titles should be below “Eryptosis,” as subcolumns. All the “ns” should be below “uRBC,” the green arrows below “iRBC,” and the first column of percentages below “Parasitemia decrease.” Lastly, the latest figures in the final publication were not used.
Table 4

Effect of eryptosis inducers on P. berghei in vivo development.

P. berghei in vivo assay
CompoundEryptosisParasi-temia decreaseMice survivalAnemia effectReferences
uRBCiRBC
Eryptosis inducersAmiodaronens64%70%N/ABobbala et al., 2010b
Anandamidens67%70%N/ABobbala et al., 2010a
Aurothiomalatens44%55%Alesutan et al., 2010
Dimethylfumaratens83%60%nsGhashghaeinia et al., 2010
Amphotericin Bnsns50%N/ASiraskar et al., 2010

Eryptosis compounds were administered to P. berghei-infected mice 8 days post-parasite infection. Eryptosis features of infected red blood cells (iRBC) and bystander uninfected red blood cells (uRBC), as well as parasitemia levels, mice survival outcome, and anemia levels effects were measured every day. For clarity purposes, the eryptosis phenotype observed is based only on reported PS exposure measurements. “Parasitemia decrease” indicates the decreased percentage in parasitemia of treated mice when compared to the untreated control (value calculated based on data provided in the original publication) when the difference reached significance. “Mice survival” indicates the percentage of viable treated mice when untreated controls reached 100% lethality rate. Compounds previously described as eryptotic inducers (see Table 1) that did not induce a significant increase in eryptosis of uRBC in these studies are indicated by .

Effect of eryptosis inducers on P. berghei in vivo development. Eryptosis compounds were administered to P. berghei-infected mice 8 days post-parasite infection. Eryptosis features of infected red blood cells (iRBC) and bystander uninfected red blood cells (uRBC), as well as parasitemia levels, mice survival outcome, and anemia levels effects were measured every day. For clarity purposes, the eryptosis phenotype observed is based only on reported PS exposure measurements. “Parasitemia decrease” indicates the decreased percentage in parasitemia of treated mice when compared to the untreated control (value calculated based on data provided in the original publication) when the difference reached significance. “Mice survival” indicates the percentage of viable treated mice when untreated controls reached 100% lethality rate. Compounds previously described as eryptotic inducers (see Table 1) that did not induce a significant increase in eryptosis of uRBC in these studies are indicated by . The publisher apologizes for this mistake. The original version of this article has been updated.
  5 in total

1.  Protective effect of amiodarone in malaria.

Authors:  Diwakar Bobbala; Ioana Alesutan; Michael Föller; Serena Tschan; Stephan M Huber; Florian Lang
Journal:  Acta Trop       Date:  2010-05-27       Impact factor: 3.112

2.  Effect of amphotericin B on parasitemia and survival of plasmodium berghei-infected mice.

Authors:  Balasaheb Siraskar; Adil Ballal; Diwakar Bobbala; Michael Föller; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2010-08-24

3.  Effect of anandamide in Plasmodium Berghei-infected mice.

Authors:  Diwakar Bobbala; Ioana Alesutan; Michael Föller; Stephan M Huber; Florian Lang
Journal:  Cell Physiol Biochem       Date:  2010-08-24

4.  Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling.

Authors:  Mehrdad Ghashghaeinia; Diwakar Bobbala; Thomas Wieder; Saisudha Koka; Jürgen Brück; Birgit Fehrenbacher; Martin Röcken; Martin Schaller; Florian Lang; Kamran Ghoreschi
Journal:  Am J Physiol Cell Physiol       Date:  2010-07-14       Impact factor: 4.249

5.  Beneficial effect of aurothiomalate on murine malaria.

Authors:  Ioana Alesutan; Diwakar Bobbala; Syed M Qadri; Adriana Estremera; Michael Föller; Florian Lang
Journal:  Malar J       Date:  2010-05-07       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.